Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Study explores novel therapeutic treatment for glioblastoma
Glioblastoma (GBM) is the most lethal brain tumour, with a median survival rate of merely…
Researchers use AI to identify sex-specific risks associated with brain tumours
For years, cancer researchers have noticed that more men than women get a lethal form…
Scientists discover that special immune cells stop metastatic cancer
Metastatic disease—when cancer spreads from the primary tumour to other parts of the body—is the…
Metastatic prostate cancer: New clinical trial tests innovative ways to preserve muscle mass
- Higher doses of radiotherapy cut treatment time by up to 75 per cent in localised prostate cancer patients, while maintaining high cure rates
- Scientists identify 11 new genes linked to aggressive prostate cancer
- Prostate cancer screening: Men who spent adequate time with their doctors are more likely to have productive discussions
A dangerous parasite could be used to treat cancer – new research in mice
Hany Elsheikha, University of Nottingham A parasite commonly found in cats’ faeces might one day help treat cancer. My colleagues…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.